Literature DB >> 12930521

Effect of age on immunoglobulin A subclass distribution in human parotid saliva.

N K Childers1, C Greenleaf, F Li, A P Dasanayake, W D Powell, S M Michalek.   

Abstract

Two subclasses of immunoglobulin A (IgA) antibodies are produced in humans, IgA1 and IgA2, IgA2 being more resistant to digestion by bacterial proteases than IgA1. The amount of IgA in saliva has been shown to vary with age; however, little is known about the correlation between IgA subclass distribution in saliva and age. The purpose of this study was to determine whether differences exist in the levels and ratio of IgA subclasses in parotid saliva of children and adults. Parotid saliva was obtained from healthy children (age range 6-12 years, n = 14) and adults (age range 22-51 years, n = 20) using Schaefer cups. Samples were analyzed for levels of total IgA, IgA1, and IgA2 by ELISA. IgA and IgA1 levels were significantly higher in adults than in children. However, no differences were seen in the ratio of IgA1 and IgA2 in the two groups of subjects. These findings indicate that levels of IgA increase with age, whereas the IgA subclass ratio is established early in life.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930521     DOI: 10.1034/j.1399-302x.2003.00084.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  9 in total

1.  Characterization of salivary immunoglobulin A responses in children heavily exposed to the oral bacterium Streptococcus mutans: influence of specific antigen recognition in infection.

Authors:  Ruchele D Nogueira; Alessandra C Alves; Marcelo H Napimoga; Daniel J Smith; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids.

Authors:  Sari H Pakkanen; Jussi M Kantele; Zina Moldoveanu; Spencer Hedges; Miikka Häkkinen; Jiri Mestecky; Anu Kantele
Journal:  Clin Vaccine Immunol       Date:  2010-01-20

3.  Assessment of Age-Related Changes of Salivary Immunoglobulin A Levels among Healthy Individuals.

Authors:  Manishkumar Dinkar Shete; Dipak Baliram Patil; Priyatam Karade; Rutuja Chopade; Neha Gandhi; Uddhav Alane
Journal:  J Pharm Bioallied Sci       Date:  2021-06-05

4.  Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity.

Authors:  Stefani N Thomas; Amy B Karger; Ghaith Altawallbeh; Kathryn M Nelson; David R Jacobs; Jed Gorlin; Helene Barcelo; Bharat Thyagarajan
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

5.  Interactions of sexual activity, gender, and depression with immunity.

Authors:  Tierney Lorenz; Sari van Anders
Journal:  J Sex Med       Date:  2013-02-28       Impact factor: 3.802

6.  Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins.

Authors:  Kiran S Ambatipudi; Bingwen Lu; Fred K Hagen; James E Melvin; John R Yates
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

7.  Determination of levels of salivary IgA subclasses in patients with minor recurrent aphthous ulcer.

Authors:  Ramandeep Saluja; Alka Kale; Seema Hallikerimath
Journal:  J Oral Maxillofac Pathol       Date:  2012-01

8.  Developmental profiles of mucosal immunity in pre-school children.

Authors:  Patricia Ewing; Diana C Otczyk; Stefano Occhipinti; Jennelle M Kyd; Maree Gleeson; Allan W Cripps
Journal:  Clin Dev Immunol       Date:  2010-12-27

9.  Salivary Biomarkers (Opiorphin, Cortisol, Amylase, and IgA) Related to Age, Sex, and Stress Perception in a Prospective Cohort of Healthy Schoolchildren.

Authors:  Anna Krahel; Elzbieta Paszynska; Justyna Otulakowska-Skrzynska; Szymon Rzatowski; Amadeusz Hernik; Agnieszka Slopien; Tomasz Hanć; Paula Szczesniewska; Ewa Bryl; Yves Boucher; Marta Tyszkiewicz-Nwafor; Maria Gawriolek; Monika Dmitrzak-Weglarz
Journal:  Mediators Inflamm       Date:  2021-11-12       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.